X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
oncology (6) 6
chemotherapy (5) 5
index medicus (5) 5
survival (5) 5
care and treatment (4) 4
adult (3) 3
cancer (3) 3
cancer research (3) 3
female (3) 3
humans (3) 3
aged (2) 2
analysis (2) 2
antineoplastic agents, alkylating - administration & dosage (2) 2
antineoplastic combined chemotherapy protocols - therapeutic use (2) 2
breast cancer (2) 2
confidence intervals (2) 2
cyclophosphamide (2) 2
cyclophosphamide - administration & dosage (2) 2
disease-free survival (2) 2
docetaxel (2) 2
dosage and administration (2) 2
efficacy (2) 2
endocrine therapy (2) 2
epidermal growth factor (2) 2
genetics (2) 2
her2 (2) 2
history (2) 2
metastases (2) 2
metastasis (2) 2
middle aged (2) 2
ovarian cancer (2) 2
ovarian neoplasms - drug therapy (2) 2
ovarian neoplasms - pathology (2) 2
phase-ii trial (2) 2
quality of life (2) 2
retrospective studies (2) 2
safety (2) 2
therapy (2) 2
trastuzumab (2) 2
treatment outcome (2) 2
1st-line treatment (1) 1
223ra‐dichloride (1) 1
abemaciclib (1) 1
administration, metronomic (1) 1
advanced breast cancer, hormonal therapy (1) 1
aged, 80 and over (1) 1
angiogenesis (1) 1
anthracyclines (1) 1
anthracyclines - administration & dosage (1) 1
antibodies, monoclonal, humanized - administration & dosage (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents, alkylating - adverse effects (1) 1
antineoplastic agents, alkylating - therapeutic use (1) 1
antiproliferative properties (1) 1
antriebsleistung (1) 1
axillary lymph-node (1) 1
benutzeroberfläche (1) 1
bevacizumab (1) 1
bone (1) 1
bone cancer (1) 1
bone metastases (1) 1
brain metastasis (1) 1
breast neoplasms - drug therapy (1) 1
breast neoplasms - metabolism (1) 1
breast neoplasms - mortality (1) 1
cancer patients (1) 1
cancer therapies (1) 1
carboplatin - administration & dosage (1) 1
carcinoma, ductal, breast - drug therapy (1) 1
carcinoma, ductal, breast - metabolism (1) 1
carcinoma, ductal, breast - mortality (1) 1
case report (1) 1
castration (1) 1
catholic church history (1) 1
catholic church. diocese of ferrara (1) 1
cell biology (1) 1
chemotherapy, adjuvant (1) 1
chiappini, luciano (1) 1
church history (1) 1
cleopatra (1) 1
colleges & universities (1) 1
colonic neoplasms - complications (1) 1
colonic neoplasms - secondary (1) 1
colonic neoplasms - surgery (1) 1
colostomy (1) 1
combination (1) 1
complete remission (1) 1
cyclophosphamide - adverse effects (1) 1
cyclophosphamide - therapeutic use (1) 1
cystadenocarcinoma, serous - drug therapy (1) 1
cystadenocarcinoma, serous - secondary (1) 1
cystadenocarcinoma, serous - surgery (1) 1
dna interaction (1) 1
drug administration schedule (1) 1
drug dosages (1) 1
drug evaluation (1) 1
drug resistance, neoplasm (1) 1
drug therapy (1) 1
drugs (1) 1
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Inorganic Biochemistry, ISSN 0162-0134, 01/2020, Volume 202, p. 110874
New pyridinimino complexes of platinum(II) [PtCl (N^N-R)] (N^N = 2-pyridylmethanimino, R = -(CH ) O(CH ) OH, -(CH) O(CH ) OCH Pyr), Pyr = pyren-1-yl) have been... 
Antiproliferative properties | Pyridinimino platinum(II) complexes | Intercalation | DNA interaction | Groove binding
Journal Article
Journal of Cellular Physiology, ISSN 0021-9541, 06/2019, Volume 234, Issue 6, pp. 7708 - 7717
Journal Article
Journal Article
BMC Cancer, ISSN 1471-2407, 04/2007, Volume 7, Issue 1, pp. 65 - 65
Journal Article
Journal of Cancer Research and Clinical Oncology, ISSN 0171-5216, 7/2013, Volume 139, Issue 7, pp. 1229 - 1240
Trastuzumab and chemotherapy is the current standard of care in HER2+ early or locally advanced breast cancer, but there are scanty literature data of its real... 
Medicine & Public Health | Hematology | Pathological complete response | Oncology | Cancer Research | Internal Medicine | Neoadjuvant | Breast cancer | HER2 | Survival | Trastuzumab | SURGICAL ADJUVANT BREAST | INDUCTION CHEMOTHERAPY | COMPLETE REMISSION | AXILLARY LYMPH-NODE | STAGE-II | PHASE-II TRIAL | PREOPERATIVE CHEMOTHERAPY | ONCOLOGY | SYSTEMIC TREATMENT | INTERNATIONAL EXPERT PANEL | Neoplasms, Hormone-Dependent - metabolism | Multivariate Analysis | Neoplasms, Hormone-Dependent - mortality | Receptor, ErbB-2 - genetics | Humans | Middle Aged | Receptor, ErbB-2 - metabolism | Carcinoma, Ductal, Breast - mortality | Breast Neoplasms - metabolism | Carcinoma, Ductal, Breast - drug therapy | Anthracyclines - administration & dosage | Antibodies, Monoclonal, Humanized - administration & dosage | Adult | Female | Neoadjuvant Therapy | Retrospective Studies | Chemotherapy, Adjuvant | Carcinoma, Ductal, Breast - metabolism | Gene Expression | Kaplan-Meier Estimate | Proportional Hazards Models | Treatment Outcome | Breast Neoplasms - drug therapy | Disease-Free Survival | Taxoids - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Breast Neoplasms - mortality | Aged | Neoplasms, Hormone-Dependent - drug therapy | Anthracyclines | Chemotherapy | Analysis | Cancer | Original Paper
Journal Article
International journal of cancer, ISSN 0020-7136, 07/2019
We analyzed data from 738 HER2-positive metastatic breast cancer (mbc) patients treated with pertuzumab-based regimens and/or T-DM1 at 45 Italian centers.... 
Journal Article
Lecture Notes in Electrical Engineering, ISSN 1876-1100, 2017, Volume 409, pp. 205 - 218
Journal Article
Cancer Biology & Therapy, ISSN 1538-4047, 02/2019, Volume 20, Issue 2, pp. 192 - 200
We carried out a retrospective observational study of 264 HER2-positive advanced breast cancer (ABC) patients to explore the efficacy of first-line treatment... 
trastuzumab | metastatic breast cancer | pertuzumab | first-line treatment | HER2 | maintenance | endocrine therapy | SURVIVAL | EFFICACY | SAFETY | DOCETAXEL | CHEMOTHERAPY | PACLITAXEL | PHASE-II TRIAL | THERAPY | ONCOLOGY | CLEOPATRA | PLUS
Journal Article
Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics), ISSN 0302-9743, 2016, Volume 9599, pp. 375 - 384
Conference Proceeding
Journal of cellular physiology, 12/2018
Data from 423 human epidermal growth factor receptor 2-negative (HER2-), hormone receptor-positive (HR+) advanced breast cancer (aBC) patients treated with... 
Journal Article
2000, Atti e memorie, ISBN 9788882690267, Volume ser. 4, v. 17, xviii, 683
Book
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.